The use of antidotes in the management of central nervous system depression.
Ferrer
A
A
Servicio de Toxicología, Hospital Clínico, Zaragoza, Spain.
Civeira
E
E
Lopez
P
P
Loren
B
B
D000931:Antidotes / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000506:poisoning; D002492:Central Nervous System Depressants / Q000506:poisoning*; D002493:Central Nervous System Diseases / Q000139:chemically induced / Q000188:drug therapy*; D004635:Emergency Medicine; D000431:Ethanol / Q000506:poisoning; D005442:Flumazenil / Q000627:therapeutic use*; D006801:Humans; D009270:Naloxone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009294:Narcotics / Q000506:poisoning
D000931:Antidotes; D002492:Central Nervous System Depressants; D009292:Narcotic Antagonists; D009294:Narcotics; D001569:Benzodiazepines; D009270:Naloxone; D000431:Ethanol; D005442:Flumazenil